MAURA APOTEK AS
Score · fiscal year 2025
45of 100
How to read this: the company is ahead of 40 % of small companies in the same sector in 2025. What does this mean?
Rank: 23,357 of 38,671 · Handel
Profile
Cheetah · Sprinter
High profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 67 and solidity 14 out of 100 among small companies in the same sector in 2025. Methodology
Against the sector
MAURA APOTEK AS is 5 points below the median for small companies in the same sector in 2025.
Median score 50 among 36,111 companies.
Against small companies in the same sector in 2025: operating margin 3.9% (median 2.5%) and equity ratio 4.7% (median 38.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 36 MNOK | 3 MNOK |
| Operating margin | 3.9% | 2.5% |
| Profit margin | 3.9% | 2.2% |
| Return on assets | 18.4% | 4.0% |
| Equity ratio | 4.7% | 38.3% |
| Debt-to-equity | 20.48 | 0.99 |
| Current ratio | 0.86 | 1.70 |
| Revenue growth | 9.6% | 3.5% |
| Revenue per employee | 2.58 MNOK | 1.62 MNOK |
The median and “ahead of” refer to small companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 45, MAURA APOTEK AS does better than 40% of small companies in the same sector (36,580 companies) in 2025.
Score 2023–2025
- MAURA APOTEK AS
- Median: small companies in the same sector
MAURA APOTEK AS has a score of 45 for 2025, rank 23,357 of 38,671 in the sector.
Strongest: Profitability: percentile 67 against peers, operating margin 3.9% against a median of 2.5%. Growth: percentile 63 against peers, revenue growth 9.6% against a median of 3.5%.
Weakest: Solidity: percentile 14 against peers, equity ratio 4.7% against a median of 38.3%. Liquidity: percentile 20 against peers, current ratio 0.86 against a median of 1.70.
Worth a closer look
- The equity ratio is very low. Could the company absorb a bad year, and does it need more equity? Based on: equity ratio 4.7% (median 38.3%).
- Consider strengthening liquidity: current liabilities are 1.2 times current assets. Based on: current ratio 0.86 (median 1.70).
- What lies behind weak solidity, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
MAURA APOTEK AS had an operating margin of 3.9% and an equity ratio of 4.7% in 2025, and ranks 23,357 of 38,671 in Handel.
From 2024 to 2025: the equity ratio fell from 22.9% to 4.7% and the operating margin fell from 6.2% to 3.9%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 0 MNOK and 13 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 11 MNOK |
| EV/EBIT | 8.0 | 13 MNOK |
| P/B | 1.0 | 0 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
The equity ratio is very low. Could the company absorb a bad year, and does it need more equity?
Based on: Equity ratio 4.7% (median 38.3%).
- watch
Consider strengthening liquidity: current liabilities are 1.2 times current assets.
Based on: Current ratio 0.86 (median 1.70).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.0% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 67 | weight 30% |
|---|---|---|
| Solidity | 14 | weight 25% |
| Liquidity | 20 | weight 15% |
| Growth | 63 | weight 15% |
| Consistency | 57 | weight 15% |
Durability: 49 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is MAURA APOTEK AS?
The operating margin was 3.9% in 2025, against a median of 2.5% among small companies in the same sector. Return on assets was 18.4%.
How solid is MAURA APOTEK AS?
The equity ratio was 4.7% in 2025 (median 38.3%). Debt-to-equity was 20.48 (median 0.99).
What is the liquidity of MAURA APOTEK AS like?
The current ratio was 0.86 in 2025 (median 1.70). Current assets did not cover current liabilities.
How does MAURA APOTEK AS compare in Handel?
MAURA APOTEK AS ranks 23,357 of 38,671 in Handel for 2025. Among companies of the same size (small companies) it ranks 21,793 of 36,580. Revenue changed by 9.6% from the year before.
From the Central Coordinating Register
- Org. no.
- 813650452
- Legal form
- AS
- Sector
- Handel (47.730)
- Size tier
- small
- Employees
- 14 registered 10 October 2026
- Founded
- 2 May 2014 12 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Vålaugsvegen 147, 2032 MAURA (NANNESTAD)
- Municipality
- Nannestad rank 14–37 of 38 in KOSTRA group 7
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Jørgen Kvernstad
- Chair of the board
- Hanne Merete Andresen
- Board member
- Pål Andrew Andersen
- Auditor
- AMICA REVISJON AS
- Accountant
- HASLESTAD REGNSKAP AS
Source: Central Coordinating Register, fetched 27 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 26 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 49 | 54 | 45 | |
| Rank | 17,753 | 16,067 | 23,357 | |
| Operating margin | 7.2% | 6.2% | 3.9% | |
| Return on assets | 23.7% | 26.5% | 18.4% | |
| Equity ratio | 18.5% | 22.9% | 4.7% | |
| Current ratio | 1.21 | 0.86 | 0.86 | |
| Revenue growth | – | 9.7% | 9.6% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 30.1 MNOK | 33.0 MNOK | 36.2 MNOK |
| Operating profit | 2.2 MNOK | 2.0 MNOK | 1.4 MNOK |
| Profit before tax | 2.2 MNOK | 2.1 MNOK | 1.4 MNOK |
| Net profit | 1.7 MNOK | 1.7 MNOK | 1.1 MNOK |
| Financial expenses | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Total assets | 9.1 MNOK | 8.1 MNOK | 7.7 MNOK |
| Current assets | 9.0 MNOK | 5.4 MNOK | 4.9 MNOK |
| Equity | 1.7 MNOK | 1.9 MNOK | 0.4 MNOK |
| Retained earnings | 1.6 MNOK | 1.8 MNOK | 0.3 MNOK |
| Total liabilities | 7.4 MNOK | 6.3 MNOK | 7.3 MNOK |
| Current liabilities | 7.4 MNOK | 6.3 MNOK | 5.7 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 6834418.
Further
Similar companies
- GRENLAND DØR OG VINDU AS index 45, rank 23,353 · compare
- RANDABERG APOTEK AS index 45, rank 23,354 · compare
- DIN FLAMME AS index 45, rank 23,355 · compare
- PIT STOP LUNDE AS index 45, rank 23,356 · compare
- BLUE GLACIER AS index 45, rank 23,358 · compare